Acromegaly management includes surgery, medical therapy, and RT and aims to reduce the GH and IGF-1 levels, manage tumor volume, decrease the risk of creating systemic concomitant disease, and decrease mortality [14, 34, 35]. This evidence concerns the gene GH1 and neoplasm.